Arcutis Biotherapeutics, Inc.
ARQT
21 insider filings · Latest: May 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Feb 2 11:17 PM | Todd Edwards | Proposed Sale | 2,052 | $25.50 | $52.3K | — | View → |
| Feb 2, 2026 | Feb 2 11:15 PM | Latha Vairavan | Proposed Sale | 1,320 | $25.50 | $33.7K | — | View → |
| Feb 2, 2026 | Feb 2 10:48 PM | Patrick Burnett | Proposed Sale | 3,675 | $25.50 | $93.7K | — | View → |
| Feb 2, 2026 | Feb 2 10:41 PM | Todd Frank Watanabe | Proposed Sale | 19,833 | $25.50 | $505.7K | — | View → |
| Feb 2, 2026 | Feb 2 10:04 PM | Howard Welgus | Proposed Sale | 10,000 | $25.05 | $250.5K | — | View → |
| Jan 5, 2026 | Jan 5 9:01 PM | Patrick Burnett | Proposed Sale | 2,490 | $28.98 | $72.2K | — | View → |
| Jan 2, 2026 | Jan 2 9:00 PM | Howard Welgus | Proposed Sale | 10,000 | $28.96 | $289.6K | — | View → |
| Dec 31, 2025 | Dec 31 9:01 PM | Patrick Burnett | Proposed Sale | 1,697 | $29.21 | $49.6K | — | View → |
| Dec 15, 2025 | Dec 15 9:07 PM | Patrick Burnett | Proposed Sale | 11,500 | $28.94 | $332.9K | — | View → |
| Dec 1, 2025 | Dec 1 9:07 PM | Howard Welgus | Proposed Sale | 10,000 | $30.21 | $302.1K | — | View → |
| Dec 1, 2025 | Dec 1 9:06 PM | Masaru Matsuda | Proposed Sale | 1,657 | $30.23 | $50.1K | — | View → |
| Nov 24, 2025 | Nov 24 9:01 PM | Sue-Jean Lin | Proposed Sale | 25,272 | $30.78 | $778.0K | — | View → |
| Nov 24, 2025 | Nov 24 8:55 PM | Todd Franklin Watanabe | Proposed Sale | 48,945 | $30.36 | $1.5M | — | View → |
| Nov 21, 2025 | Nov 21 9:49 PM | Todd Franklin Watanabe | Proposed Sale | 1,055 | $30.00 | $31.6K | — | View → |
| Nov 20, 2025 | Nov 20 9:24 PM | Halley Gilbert | Proposed Sale | 16,532 | $27.55 | $455.4K | — | View → |
| Nov 19, 2025 | Nov 19 9:20 PM | Masaru Matsuda | Proposed Sale | 2,550 | $28.29 | $72.1K | — | View → |
| Nov 13, 2025 | Nov 13 9:05 PM | Neha Krishnamohan | Proposed Sale | 40,504 | $23.19 | $939.3K | — | View → |
| Nov 6, 2025 | Nov 6 10:49 PM | Patrick Burnett | Proposed Sale | 17,250 | $24.18 | $417.1K | — | View → |
| Nov 6, 2025 | Nov 6 9:54 PM | Todd Edwards | Proposed Sale | 29,131 | $25.16 | $732.9K | — | View → |
| Nov 5, 2025 | Nov 5 10:29 PM | Patrick Burnett | Proposed Sale | 3,846 | $23.72 | $91.2K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 4 9:17 PM | Keith R LeonardDirector | Option Exercise | 39,272 | $8.63 | 0(D) | View → |
| Feb 27, 2026 | Mar 4 1:43 AM | Larry Todd EdwardsReporting Person's title: EVP, Chief Commercial Officer | Grant/Award | 77,000 | $26.97 | 77,000(D) | View → |
| Feb 27, 2026 | Mar 4 1:42 AM | Todd WatanabeDirector, Reporting Person's title: President and Chief Executive Officer | Grant/Award | 266,000 | $26.97 | 266,000(D) | View → |
| Feb 27, 2026 | Mar 4 1:42 AM | Masaru MatsudaReporting Person's title: EVP, Chief Legal Officer | Grant/Award | 97,000 | $26.97 | 97,000(D) | View → |
| Feb 27, 2026 | Mar 4 1:42 AM | Latha VairavanSVP Chief Financial Officer | Grant/Award | 70,000 | $26.97 | 70,000(D) | View → |
| Feb 27, 2026 | Mar 4 1:41 AM | Patrick BurnettReporting Person's title: EVP, Chief Medical Officer | Grant/Award | 77,000 | $26.97 | 77,000(D) | View → |